Intercept Pharmaceuticals, Inc.

MetLife Investment Management, LLC

Report date

9/30/2023

Quarter

2023 Q3

Filed

5/9/2024

Shares

21,600

Value ($000)

400

Weight

0.0%

2018 Q3 - 2023 Q3 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	5/9/2024	400	0.0%	21,600	9/30/2023
2023 Q2	4/29/2024	141	0.0%	12,747	6/30/2023
2023 Q1	5/9/2024	171	0.0%	12,747	3/31/2023
2022 Q4	5/10/2024	158	0.0%	12,747	12/31/2022
2022 Q3	5/10/2024	178	0.0%	12,747	9/30/2022
2022 Q2	5/10/2024	228	0.0%	16,476	6/30/2022
2022 Q1	5/10/2024	268	0.0%	16,476	3/31/2022
2021 Q4	5/17/2024	183	0.0%	11,215	12/31/2021
2021 Q3	5/17/2024	167	0.0%	11,215	9/30/2021
2021 Q2	5/17/2024	224	0.0%	11,215	6/30/2021
2021 Q1	5/17/2024	259	0.0%	11,215	3/31/2021
2020 Q4	5/24/2024	277	0.0%	11,215	12/31/2020
2020 Q3	5/24/2024	465	0.0%	11,215	9/30/2020
2020 Q2	5/24/2024	537	0.0%	11,215	6/30/2020
2020 Q1	7/12/2023	706	0.0%	11,215	3/31/2020
2019 Q4	7/12/2023	1,390	0.0%	11,215	12/31/2019
2019 Q3	7/12/2023	744	0.0%	11,215	9/30/2019
2019 Q2	7/12/2023	892	0.0%	11,215	6/30/2019
2019 Q1	7/13/2023	1,083	0.0%	9,678	3/31/2019
2018 Q4	7/13/2023	975	0.0%	9,678	12/31/2018
2018 Q3	7/13/2023	1,166	0.0%	9,225	9/30/2018